Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,780.40
(
-0.07%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.36
(
-2.08%
)
Bitcoin
70,451.20
(
-1.11%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

xrymd

Send PM Follow Ignore
Followers 31
Posts 1187
Boards Moderated 0
Alias Born 08/23/2004

xrymd

Member Level

Re: DewDiligence post# 154712

Monday, 12/31/2012 12:03:10 PM

Monday, December 31, 2012 12:03:10 PM

Post# of 257262
Uveitis is a full-fledged phase-3 program including three trials; the program is partnered with Servier

I thought that uveitis was a small niche market. The company was always talking about Diabetes and the past results were not great. Now they seem to be taking a shot at CV. Seems like a stretch for them.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now